Cargando…

Correction to: Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545495/ https://www.ncbi.nlm.nih.gov/pubmed/37365902 http://dx.doi.org/10.1093/brain/awad208

Ejemplares similares

Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
por: Gonzalez-Ortiz, Fernando, et al.
Publicado: (2022)

Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K., et al.
Publicado: (2018)

Author Correction: Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Hashimoto, Shoko, et al.
Publicado: (2019)

Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease
por: Jiao, S-S, et al.
Publicado: (2016)

The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer’s Disease Type
por: Pluta, Ryszard, et al.
Publicado: (2021)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
por: Lamontagne-Kam, Daniel, et al.
Publicado: (2023)

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease
por: Toombs, Jamie, et al.
Publicado: (2020)

Tau as a Biomarker of Neurodegeneration
por: Holper, Sarah, et al.
Publicado: (2022)

Mechanism of neurodegeneration through tau and therapy for Alzheimer's disease
por: Takashima, Akihiko
Publicado: (2016)

Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2020)

Correction to: Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer’s disease
por: Sun, Yao, et al.
Publicado: (2021)

Correction to: Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
por: Bai, Bing, et al.
Publicado: (2021)

Correction: Tau-Mediated Nuclear Depletion and Cytoplasmic Accumulation of SFPQ in Alzheimer's and Pick's Disease
por: Ke, Yazi, et al.
Publicado: (2012)

Correction: Diagnostic and prognostic performance to detect Alzheimer’s disease and clinical progression of a novel assay for plasma p-tau217
por: Groot, Colin, et al.
Publicado: (2022)

Author Correction: APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids
por: Zhao, Jing, et al.
Publicado: (2021)

Blood-Based Transcriptomic Biomarkers Are Predictive of Neurodegeneration Rather Than Alzheimer’s Disease
por: Shvetcov, Artur, et al.
Publicado: (2023)

Correction: Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer's Disease
Publicado: (2015)

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
por: Visser, Pieter Jelle, et al.
Publicado: (2022)

Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
por: Duan, Yale, et al.
Publicado: (2012)

The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection
por: Quntanilla, Rodrigo A., et al.
Publicado: (2020)

Author Correction: Pericyte loss influences Alzheimer-like neurodegeneration in mice
por: Sagare, Abhay P., et al.
Publicado: (2023)

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
por: Moscoso, Alexis, et al.
Publicado: (2021)

Correction: Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease
por: Chen, Xuesong, et al.
Publicado: (2023)

Correction to: Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
por: Shi, Yang, et al.
Publicado: (2021)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum
por: Chen, Yi-He, et al.
Publicado: (2022)

Correction: A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
Publicado: (2014)

Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
por: Iaccarino, Leonardo, et al.
Publicado: (2017)

Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease
por: Wu, Xi-Lin, et al.
Publicado: (2017)

Tau as a fluid biomarker of concussion and neurodegeneration
por: Hossain, Iftakher, et al.
Publicado: (2022)

Author Correction: Molecular estimation of neurodegeneration pseudotime in older brains
por: Mukherjee, Sumit, et al.
Publicado: (2020)

Correction: Hoshi et al. High Correlation among Brain-Derived Major Protein Levels in Cerebrospinal Fluid: Implication for Amyloid-Beta and Tau Protein Changes in Alzheimer’s Disease. Metabolites 2022, 12, 355
por: Hoshi, Kyoka, et al.
Publicado: (2023)

Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer’s disease dementia in Chinese individuals
por: Sun, Qingling, et al.
Publicado: (2022)

Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
por: Milà-Alomà, Marta, et al.
Publicado: (2022)

Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
por: Vogel, Jacob W., et al.
Publicado: (2021)

Correction: Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration
Publicado: (2021)

Correction: Ku70 Alleviates Neurodegeneration in Drosophila Models of Huntington's Disease
por: Tamura, Takuya, et al.
Publicado: (2012)

Brain aging, epigenetic changes, tau and neurodegeneration
por: Avila, Jesús
Publicado: (2021)

Correction to “A novel, likely pathogenic variant in UBTF‐related neurodegeneration with brain atrophy is associated with a severe divergent neurodevelopmental phenotype”
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_admm87voh5o1fqrncd3a0ifj0k